Manufacture of CKD furniture and limitation: assembled components were excisable, but extended period and penalties failed.

Assembly of imported CKD furniture components with locally procured parts into complete tables, chairs, cabinets, filing racks and modular workstations constitutes manufacture, because distinct commercial furniture emerges for central excise purposes under Chapter 9403. The fact that the goods were imported in CKD form and classified differently under customs law did not negate manufacture. However, extended limitation and penalties were not sustainable where the assessee acted under a bona fide belief on an arguable classification issue and suppression was not established. Where duty is otherwise payable, cum-duty treatment and Cenvat credit may be allowed subject to verification of invoices and duty-paid inputs, and the matter was remanded for recomputation on the normal period with consequential relief.

---

---

Issues: (i) whether assembly of imported CKD furniture components with locally procured parts resulted in manufacture of excisable furniture under Chapter 9403; (ii) whether invocation of the extended period of limitation and imposition of penalties on the assessee and the Director were justified; (iii) whether cum-duty benefit and Cenvat credit were admissible if duty was payable.

Issue (i): whether assembly of imported CKD furniture components with locally procured parts resulted in manufacture of excisable furniture under Chapter 9403.

Analysis: The assembled items were found to emerge as distinct commercial furniture such as tables, chairs, storage cabinets, filing racks and modular workstations. The imported goods were not imported as finished products alone, but were assembled with indigenous components at the assessee's premises or customer sites to bring into existence complete furniture. The evidence relied upon by the adjudicating authority showed that the workstations were movable and could be dismantled and reinstalled, and the classification under customs law did not negate manufacture for central excise purposes.

Conclusion: The process amounted to manufacture and the resultant goods were excisable furniture classifiable under Chapter 9403.

Issue (ii): whether invocation of the extended period of limitation and imposition of penalties on the assessee and the Director were justified.

Analysis: Although manufacture was upheld, the demand for the earlier period rested on suppression even though the classification issue had been the subject of judicial doubt and the assessee had proceeded under a bona fide belief that duty was not payable again after customs duty on CKD imports. On the facts, the longer limitation period was not sustainable. In consequence, the basis for penalty also failed, including the personal penalty on the Director.

Conclusion: The extended period was not justified and the penalties were unsustainable.

Issue (iii): whether cum-duty benefit and Cenvat credit were admissible if duty was payable.

Analysis: Where duty is otherwise payable, the sale price has to be treated as cum-duty price if supported by proper invoices and the availability of credit depends on proof of duty-paid inputs. The matter therefore required recomputation on the normal period with the relevant benefits subject to verification of documents.

Conclusion: Cum-duty benefit and Cenvat credit were admissible subject to production of necessary documents.

Final Conclusion: The finding of manufacture was sustained, but the demand was confined to the normal limitation period and the matter was sent back for recomputation with consequential relief on price and credit, while penalties were set aside.

Ratio Decidendi: Assembly of imported CKD and locally procured components into complete, movable furniture constitutes manufacture for central excise purposes, but extended limitation cannot be invoked absent sustainable suppression where the assessee acts under a bona fide belief on an arguable classification issue.

---